Price to Sales ratio Analysis of Arcutis Biotherapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-23
Very Poor PS
11814.48
Period Ending - Dec-22
Very Poor PS
124.82
Growth
9365.56 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
6.50
PS Analysis of Arcutis Biotherapeutics Inc
| P/S Ratio of Arcutis Biotherapeutics Inc with value of 6.50 indicates that stock price is high compared to sales of the company and may be overvalued. |
| PS Ratio of ARQT rose handsomely by 9365.56 % this year. |
| PS Ratio with value of 11814.48 was highest in Year Dec-23 in last Five Years. |
| PS Ratio with value of 0 was lowest in Year Dec-21 in last Five Years. |
| Latest PS Ratio with value of 11814.48 is Greater than Average PS of 2387.86 in last five years. |
Other PS Related Info of ARQT that may interest you.
Arcutis Biotherapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ARQT | 8.36 | 8.66 | 3.46 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Sales of Arcutis Biotherapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PS | 11814.48 | 124.82 | 0 | 0 | 0 | 0 | 0 |
| Change | 9365.56 % |
FY Chart of Price to Sales of Arcutis Biotherapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)